Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Human iPS cell-based therapy: considerations before clinical applications.

Sun N, Longaker MT, Wu JC.

Cell Cycle. 2010 Mar 1;9(5):880-5. Epub 2010 Mar 2. Review.

2.

Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells.

Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, Jia F, Hu S, Cherry AM, Robbins RC, Longaker MT, Wu JC.

Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15720-5. doi: 10.1073/pnas.0908450106. Epub 2009 Sep 8.

3.

Gold standards in the diamond age: the commodification of pluripotency.

Sipp D.

Cell Stem Cell. 2009 Oct 2;5(4):360-3. doi: 10.1016/j.stem.2009.09.005.

4.

Transcriptional signature and memory retention of human-induced pluripotent stem cells.

Marchetto MC, Yeo GW, Kainohana O, Marsala M, Gage FH, Muotri AR.

PLoS One. 2009 Sep 18;4(9):e7076. doi: 10.1371/journal.pone.0007076.

5.

Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells.

Utikal J, Maherali N, Kulalert W, Hochedlinger K.

J Cell Sci. 2009 Oct 1;122(Pt 19):3502-10. doi: 10.1242/jcs.054783. Epub 2009 Sep 1.

6.

Variation in the safety of induced pluripotent stem cell lines.

Miura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K, Nakagawa M, Koyanagi M, Tanabe K, Ohnuki M, Ogawa D, Ikeda E, Okano H, Yamanaka S.

Nat Biotechnol. 2009 Aug;27(8):743-5. doi: 10.1038/nbt.1554. Epub 2009 Jul 9.

PMID:
19590502
7.

Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures.

Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J, Khvorostov I, Ott V, Grunstein M, Lavon N, Benvenisty N, Croce CM, Clark AT, Baxter T, Pyle AD, Teitell MA, Pelegrini M, Plath K, Lowry WE.

Cell Stem Cell. 2009 Jul 2;5(1):111-23. doi: 10.1016/j.stem.2009.06.008.

8.

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins.

Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R, Kim KS.

Cell Stem Cell. 2009 Jun 5;4(6):472-6. doi: 10.1016/j.stem.2009.05.005. Epub 2009 May 28. No abstract available.

9.

A fresh look at iPS cells.

Yamanaka S.

Cell. 2009 Apr 3;137(1):13-7. doi: 10.1016/j.cell.2009.03.034.

10.

Human induced pluripotent stem cells free of vector and transgene sequences.

Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA.

Science. 2009 May 8;324(5928):797-801. doi: 10.1126/science.1172482. Epub 2009 Mar 26.

11.

Reprogramming cell fates: reconciling rarity with robustness.

Huang S.

Bioessays. 2009 May;31(5):546-60. doi: 10.1002/bies.200800189.

PMID:
19319911
12.

Generation of induced pluripotent stem cells from human blood.

Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, Kim K, Miller JD, Ng K, Daley GQ.

Blood. 2009 May 28;113(22):5476-9. doi: 10.1182/blood-2009-02-204800. Epub 2009 Mar 18.

13.

Guidelines and techniques for the generation of induced pluripotent stem cells.

Maherali N, Hochedlinger K.

Cell Stem Cell. 2008 Dec 4;3(6):595-605. doi: 10.1016/j.stem.2008.11.008. Review.

14.

Heterogeneity of embryonic and adult stem cells.

Graf T, Stadtfeld M.

Cell Stem Cell. 2008 Nov 6;3(5):480-3. doi: 10.1016/j.stem.2008.10.007. Review.

15.

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.

Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilić J, Pekarik V, Tiscornia G, Edel M, Boué S, Izpisúa Belmonte JC.

Nat Biotechnol. 2008 Nov;26(11):1276-84. doi: 10.1038/nbt.1503. Epub 2008 Oct 17.

PMID:
18931654
16.

Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.

Swijnenburg RJ, Schrepfer S, Govaert JA, Cao F, Ransohoff K, Sheikh AY, Haddad M, Connolly AJ, Davis MM, Robbins RC, Wu JC.

Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12991-6. doi: 10.1073/pnas.0805802105. Epub 2008 Aug 26.

17.

The promise of human induced pluripotent stem cells for research and therapy.

Nishikawa S, Goldstein RA, Nierras CR.

Nat Rev Mol Cell Biol. 2008 Sep;9(9):725-9. doi: 10.1038/nrm2466. Review.

PMID:
18698329
18.

Generation of human-induced pluripotent stem cells.

Park IH, Lerou PH, Zhao R, Huo H, Daley GQ.

Nat Protoc. 2008;3(7):1180-6. doi: 10.1038/nprot.2008.92.

PMID:
18600223
19.

Adipose-derived stem cells: isolation, expansion and differentiation.

Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C.

Methods. 2008 Jun;45(2):115-20. doi: 10.1016/j.ymeth.2008.03.006. Epub 2008 May 29. Review.

20.

In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation.

Swijnenburg RJ, Schrepfer S, Cao F, Pearl JI, Xie X, Connolly AJ, Robbins RC, Wu JC.

Stem Cells Dev. 2008 Dec;17(6):1023-9. doi: 10.1089/scd.2008.0091.

Supplemental Content

Support Center